Oral contraceptives and compliance: reaction to cardiovascular alarm among users

By Tydén T.  

Advances in Contraception, Vol. 15, Iss. 2, 1999-01 ,pp. : 133-139

Springer Publishing Company

Access to resources Recommend Favorite

The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women

By van der Mooren M.J.   Demacker P.N.M.   Blom H.J.   de Rijke Y.B.   Rolland R.  

Fertility and Sterility, Vol. 67, Iss. 1, 1997-01 ,pp. : 67-73

Elsevier

Access to resources Recommend Favorite

Cardiovascular aspects of menopausal hormone replacement therapy

By Rosano G. M. C.   Vitale C.   Fini M.  

Climacteric, Vol. 12, Iss. 1, 2009-08 ,pp. : 41-46

Informa Healthcare

Access to resources Recommend Favorite

Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study

By Nickelsen T.   Creatsas G.   Rechberger T.   Depypere H.   Erenus M.   Quail D.   Arndt T.   Bonnar J.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 320-331

Informa Healthcare

Access to resources Recommend Favorite

Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies

By Shapiro S.  

Climacteric, Vol. 9, Iss. 6, 2006-12 ,pp. : 416-420

Informa Healthcare

Access to resources Recommend Favorite